APA (7th ed.) Citation

A, M., C, N., I, C., F, L., V, G., AM, R., . . . L, M. (2024). Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 45(7), 3379. https://doi.org/10.1007/s10072-024-07308-y

Chicago Style (17th ed.) Citation

A, Mariottini, et al. "Cost and Effectiveness of Autologous Haematopoietic Stem Cell Transplantation and High-efficacy Disease-modifying Therapies in Relapsing-remitting Multiple Sclerosis." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 45, no. 7 (2024): 3379. https://doi.org/10.1007/s10072-024-07308-y.

MLA (9th ed.) Citation

A, Mariottini, et al. "Cost and Effectiveness of Autologous Haematopoietic Stem Cell Transplantation and High-efficacy Disease-modifying Therapies in Relapsing-remitting Multiple Sclerosis." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, vol. 45, no. 7, 2024, p. 3379, https://doi.org/10.1007/s10072-024-07308-y.